Every Zipp story tagged #Biotech, newest first.
Autonomous lab control would move Claude from answering research questions to executing physical workflows, raising both productivity and oversight questions.
The move gives Anthropic a direct foothold in experimental biology, linking a frontier AI model to one of biotech's most demanding research areas.
The move pushes Anthropic beyond model development and into applied biology, putting AI directly against some of medicine’s hardest treatment challenges.
The treasury-trade playbook that lifted Strategy's stock for two years is cracking: dilution is no longer rewarded, and a biotech is the latest to test how far shareholders will stretch.
Founders Fund-led round brings in Thrive, Greenoaks and Eli Lilly Ventures — and accelerates NewLimit's push to take its first age-reprogramming candidate into human trials in 2026.
WatcherGuru
CoinTelegraph
CryptoSlate
WuBlockchain